Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer
ByAjaz Bulbul, MD,Patrick M. Forde, MD,Ayesha Murtuza, MD,Brian Woodward,Hannah Yang,Ingmar Bastian,Parissa K. Ferguson, MS,Fernando Lopez-Diaz, PhD,David S. Ettinger, MD,Hatim Husain, MD
Published: | Updated:
In this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
